Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial-Reference-Cited by-同舟云学术

Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial

Published:2008-02 Issue:2 Volume:10 Page:149-156
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

McMurray John J.V.¹,Carson Peter E.²,Komajda Michel³,McKelvie Robert⁴,Zile Michael R.⁵,Ptaszynska Agata⁶,Staiger Christoph⁷,Donovan J. Mark⁶,Massie Barry M.⁸

Affiliation:

1. Department of Cardiology, Western Infirmary, Glasgow, and Faculty of Medicine; University of Glasgow; Scotland UK

2. Washington Veterans Affairs Medical Center and Georgetown University; Washington DC USA

3. University Pierre et Marie Curie; Paris 6; Hôpital Pitiê-Salpêtrière Paris France

4. McMaster University; Hamilton ON Canada

5. Medical University of South Carolina and Veterans' Affairs Medical Center; Charleston SC USA

6. Pharmaceutical Research Institute, Bristol Myers Squibb; Princeton NJ USA

7. Sanofi-Aventis; Bridgewater New Jersey USA

8. University of California and San Francisco Veterans Affairs Medical Center; San Francisco CA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.ejheart.2007.12.010/fullpdf

Reference35 articles.

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators;N Engl J Med,1991

2. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999

3. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial;Lancet,1999

4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF);Lancet,1999

5. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure;Packer;N Engl J Med,2001

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel echocardiographic markers for left ventricular filling pressure prediction in heart failure with preserved ejection fraction (ECHO-PREDICT): a prospective cross-sectional study;Annals of Medicine & Surgery;2023-09-13

2. Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER;European Journal of Heart Failure;2023-09

3. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension;European Journal of Heart Failure;2023-07

4. How to Manage Heart Failure With Preserved Ejection Fraction;JACC: Heart Failure;2023-06

5. Fluid management in septic patients with pulmonary hypertension, review of the literature;Frontiers in Cardiovascular Medicine;2023-03-02